IQVIA
Kevin Landells is a seasoned professional in the clinical trial technology sector, currently serving as Vice President Business Head for Cenduit IRT at IQVIA since December 2019. Kevin has been instrumental in overseeing global project management and support for approximately 500 live clinical trials. Prior to this role, Kevin held positions at Cenduit, contributing significantly to industry-leading project management and operational excellence. Kevin's extensive experience also includes a senior role at PAREXEL, where responsibilities encompassed governance of key accounts and strategic relationships in Europe, along with leadership of logistics solutions teams. Kevin began a career in clinical trial technology at ClinPhone, where management of RTSM IVR & IWR projects was a key focus. Kevin holds a Bachelor of Science degree in Computer Science from the University of Hertfordshire.
This person is not in any teams
This person is not in any offices
IQVIA
164 followers
IQVIA, formerly Quintiles IMS Holdings, Inc., is an American multinational company serving the combined industries of health information technologies and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.